Advanced Search

Technical Analysis for EVFM - Evofem Biosciences, Inc.

Grade Last Price % Change Price Change
F 2.83 0.71% 0.02
EVFM closed up 0.71 percent on Friday, January 22, 2021, on 86 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
14 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical EVFM trend table...
Date Alert Name Type % Chg
Stochastic Reached Overbought Strength 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
NR7 Range Contraction 4.43%
Calm After Storm Range Contraction 5.20%
Upper Bollinger Band Touch Strength 5.20%
1,2,3 Pullback Bullish Bullish Swing Setup 4.04%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 4.04%
Older End-of-Day Signals for EVFM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Upper Bollinger Band Resistance about 19 hours ago
1.5x Volume Pace about 20 hours ago
Up 3% about 20 hours ago
Up 2% about 20 hours ago
Rose Above Previous Day's High about 20 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators Basic chart:

Profile

Evofem Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes women's sexual and reproductive health products. Its lead product candidate is Amphora, a non-hormonal woman-controlled vaginal gel, which is in Phase 3 clinical trial for the prevention of pregnancy; and in Phase 2b trial for the prevention of chlamydia and gonorrhea in women. The company is also developing multi-purpose vaginal pH regulator gel product candidate for the reduction of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Health Products Vagina Gynaecology Human Reproduction Sexually Transmitted Diseases And Infections Chlamydia Reproductive Health

Is EVFM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jan 12 Evofem Biosciences Wins Business Intelligence Group's BIG Innovation Award 2021
Dec 28 Evofem: Initial Sales Are Highly Encouraging
Dec 22 Evofem Biosciences to Participate in Medicaid National Drug Rebate Program for Phexxi® Effective January 1, 2021
Dec 21 Evofem Biosciences to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Dec 17 Evofem Biosciences Provides Update on Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea
Dec 12 Is EVFM A Good Stock To Buy Now?
Dec 11 Evofem Biosciences Announces Orange Book Listing of Two U.S. Patents for Phexxi®
Dec 3 Evofem secures government contract for purchase of Phexxi contraceptive
Dec 3 The U.S. Department of Veterans Affairs Awards Contract to Evofem Biosciences for Phexxi®
Dec 2 Evofem Biosciences (EVFM) Presents At Piper Sandler 32nd Annual Virtual Healthcare Conference - Slideshow
See more EVFM news...

Indicators

Indicator Value
52 Week High 7.21
52 Week Low 1.91
Average Volume 2,655,789
200-Day Moving Average 3.17
50-Day Moving Average 2.37
20-Day Moving Average 2.59
10-Day Moving Average 2.71
Average True Range 0.16
ADX 43.07
+DI 30.31
-DI 7.90
Chandelier Exit (Long, 3 ATRs ) 2.44
Chandelier Exit (Short, 3 ATRs ) 2.54
Upper Bollinger Band 2.87
Lower Bollinger Band 2.31
Percent B (%b) 0.93
BandWidth 21.42
MACD Line 0.12
MACD Signal Line 0.10
MACD Histogram 0.0193
Fundamentals Value
Market Cap 230.02 Million
Num Shares 81.3 Million
EPS -3.01
Price-to-Earnings (P/E) Ratio -0.94
Price-to-Sales 464.32
Price-to-Book 4.39
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.09
Resistance 3 (R3) 3.09 3.00 3.04
Resistance 2 (R2) 3.00 2.94 3.00 3.03
Resistance 1 (R1) 2.92 2.90 2.96 2.92 3.01
Pivot Point 2.83 2.83 2.86 2.83 2.83
Support 1 (S1) 2.75 2.77 2.79 2.75 2.65
Support 2 (S2) 2.66 2.73 2.66 2.63
Support 3 (S3) 2.58 2.66 2.62
Support 4 (S4) 2.58